Cellectar Biosciences, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cellectar Biosciences, Inc. on March 6, 2015, covering events occurring on March 4, 2015. The filing serves as a Regulation FD disclosure regarding an upcoming corporate presentation.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
No material financial changes versus a prior comparable period are reported in this document. The filing focuses solely on the announcement of a scheduled conference presentation.
Outlook, Commentary, and Risks
Management announced that Dr. Jamey Weichert, Chief Scientific Officer and founder, will present at the 27th Annual Roth Conference. The presentation is scheduled for Tuesday, March 10, 2015, at 3:30 pm PDT at the Ritz Carlton in Laguna Niguel, California. No specific risks, contingencies, or unusual items are detailed in this filing.
Key Facts for Investor Verification
- Dr. Jamey Weichert is scheduled to present at the 27th Annual Roth Conference on March 10, 2015.
- The presentation time is 3:30 pm PDT at the Ritz Carlton in Laguna Niguel, California.
- A press release detailing this event is included as Exhibit 99.1.
- This filing contains no financial data or operational results.